Ronald Streck v. Eli Lilly and Company
| STATE OF NEW YORK, STATE OF TEXAS and UNITED STATES OF AMERICA |
| ASTELLAS PHARMA US, INC. and ROCHE LABORATORIES, INCORPORATED |
| RONALD J. STRECK |
| ELI LILLY AND COMPANY |
| 23-3035 |
| October 23, 2023 |
| U.S. Court of Appeals, Seventh Circuit |
| False Claims Act |
Docket Report
RSS Track this Docket
This docket was last retrieved on December 20, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 16 Circuit Rule 26.1 Disclosure Statement and Appearance filed by Attorney Mark S. Wigley for Appellant Eli Lilly and Company in 23-2134, Appellee Eli Lilly and Company in 23-2216, 23-2958, 23-3035. [16] [7354911] (L-No; E-No; R-No) [23-2134, 23-2216, 23-2958, 23-3035]--[Edited 12/21/2023 by FP to reflect that atty. Wigley is added to the docket.] (Wigley, Mark) [Entered: 12/20/2023 05:55 PM] |
| Filing 15 Circuit Rule 26.1 Disclosure Statement and Appearance filed by Attorney Luke P. McGuire for Appellant Eli Lilly and Company in 23-2134, Appellee Eli Lilly and Company in 23-2216, 23-2958, 23-3035. [15] [7352943] (L-No; E-No; R-No) [23-2134, 23-2216, 23-2958, 23-3035] (McGuire, Luke) [Entered: 12/11/2023 10:24 PM] |
| Filing 14 Circuit Rule 26.1 Disclosure Statement and Appearance filed by Attorney Matthew S. Owen for Appellant Eli Lilly and Company in 23-2134, Appellee Eli Lilly and Company in 23-2216, 23-2958, 23-3035. [14] [7352942] (L-No; E-No; R-No) [23-2134, 23-2216, 23-2958, 23-3035] (Owen, Matthew) [Entered: 12/11/2023 10:22 PM] |
| Filing 13 NOTICE: Circuit Rule 46(a) requires lead counsel be admitted to practice within 30 days of the date the appeal/petition was docketed. The rule also requires any attorney wishing to present oral argument to be admitted. Our records indicate as of this date Attorney Robert J. Martin, IV for Appellee Ronald J. Streck in 23-2958, 23-2134, for Appellant Ronald J. Streck in 23-2216, 23-3035 has/have not been admitted to practice in this court. Within 21 days, please file your application for admission by going to: https://www.ca7.uscourts.gov/forms/forms7.htm and choosing the link, "Application for Admission to Practice in the Seventh Circuit". [13] [7348249] [23-2958, 23-2134, 23-2216, 23-3035] (CAH) [Entered: 11/16/2023 09:35 AM] |
Filing 12
ORDER re: Joint Motion to Consolidate and Set Briefing Schedule [ # 4 ]. IT IS ORDERED that the briefing schedule for these consolidated appeals is revised as follows: Eli Lilly and Company shall file its opening brief and required short appendix in the main appeal docketed in Appeal Nos. 23-2134 and 23-2958 on or before 12/202023. Ronald J. Streck shall file his combined responsive brief in the main appeal and opening brief and appendix in the cross-appeal docketed in Appeal Nos. 23-2216 and 23-3035 on or before 02/23/2023. 3. Eli Lilly and Company shall file its combined reply brief, if any, in the main appeal and responsive brief in the cross-appeal on or before 04/24/2024. 4. Ronald J. Streck shall file his reply brief, if any, in the cross-appeal on or before 06/24/2024. JAF [7345907] [23-2134, 23-2216, 23-2958, 23-3035] (MAN) [Entered: 11/03/2023 03:18 PM]
|
|
Filing 11
ORDER: The court, on its own motion, orders these appeals CONSOLIDATED for purposes of briefing and disposition. JAF Main appeal brief due on or before 11/20/2023 for Eli Lilly and Company. Appellee Cross-Appellant brief due on or before 12/20/2023 for Ronald J. Streck. Appellant Reply Cross-Appellee brief due by 01/19/2024 for Appellant Eli Lilly and Company. Reply Brief in Cross Appeal due by 02/09/2024 for Appellant Ronald J. Streck. [11] [7345672] [23-2134, 23-2216, 23-2958, 23-3035] (ER) [Entered: 11/02/2023 04:13 PM]
|
| Filing 10 Circuit Rule 26.1 Disclosure Statement and Appearance filed by Attorney Mary Elizabeth Miller for Appellee Eli Lilly and Company. [10] [7345403] (L-No; E-Yes; R-No) [23-3035] (Miller, Mary) [Entered: 11/02/2023 08:16 AM] |
| Filing 9 Circuit Rule 26.1 Disclosure Statement and Appearance filed by Attorney Ryan J. Moorman for Appellee Eli Lilly and Company. [9] [7345402] (L-No; E-Yes; R-No) [23-3035] (Moorman, Ryan) [Entered: 11/02/2023 08:13 AM] |
| Filing 8 Circuit Rule 26.1 Disclosure Statement and Appearance filed by Attorney James R.P. Hileman for Appellee Eli Lilly and Company. [8] [7345401] (L-No; E-Yes; R-No) [23-3035] (Hileman, James) [Entered: 11/02/2023 08:11 AM] |
| Filing 7 Circuit Rule 26.1 Disclosure Statement and Appearance filed by Attorney Diana M. Watral for Appellee Eli Lilly and Company. [7] [7345400] (L-No; E-Yes; R-No) [23-3035] (Watral, Diana) [Entered: 11/02/2023 08:08 AM] |
| Filing 6 Circuit Rule 26.1 Disclosure Statement and Appearance filed by Attorney Andrew A. Kassof for Appellee Eli Lilly and Company. [6] [7345399] (L-No; E-Yes; R-No) [23-3035] (Kassof, Andrew) [Entered: 11/02/2023 08:06 AM] |
| Filing 5 Circuit Rule 26.1 Disclosure Statement and Appearance filed by Attorney John C. O'Quinn for Appellee Eli Lilly and Company. [5] [7345398] (L-Yes; E-Yes; R-No) [23-3035] (O'Quinn, John) [Entered: 11/02/2023 08:03 AM] |
| Filing 4 Joint motion filed by Appellee Ronald J. Streck in 23-2134, Appellant Ronald J. Streck in 23-2216, 23-2958, 23-3035 Joint Motion to Consolidate and Set Briefing Schedule. [4] [7345390] [23-2134, 23-2216, 23-2958, 23-3035] (Miller, Daniel) [Entered: 11/01/2023 06:19 PM] |
| Filing 3 Docketing Statement filed by Appellant Ronald J. Streck. Prior or Related proceedings: Yes. No. 23-2216, No. 23-2216, and No. 23-2958 [3] [7343679] [23-3035] (Miller, Daniel) [Entered: 10/24/2023 03:36 PM] |
| Filing 2 THIS CAUSE CONSISTS OF MORE THAN 3 PARTIES FOR EITHER SIDE. The following are those parties to this cause as reflected on the District Court docket, yet are not reflected on the Appellate docket/caption for administrative purposes: PLAINTIFFS: State of California, State of Colorado, State of Connecticut, State of Delaware, State of Florida, State of Georgia, State of Hawaii, State of Illinois, State of Indiana, State of Iowa, State of Louisiana, State of Maryland, Commonwealth of Massachusetts, State of Michigan, State of Minnesota, State of Montana, State of Nevada, State of New Jersey, State of New Mexico, State of North Carolina, State of Oklahoma, State of Rhode Island, State of Tennessee, Commonwealth of Virginia, State of Washington, State of Wisconsin and District of Columbia. APPELLEES: Takeda Pharmaceuticals America, Inc., Actavis, LLC, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Celgene Corporation, Daiichi Sankyo, Inc., First Horizon Pharmaceutical Corporation, Jom Pharmaceutical Services, Inc., Merk & Co., Inc., Organon USA, Inc., Teva Pharmaceuticals, USA, Inc. and Santarus, Inc. [2] [7343216] [23-3035] (MAN) [Entered: 10/23/2023 02:42 PM] |
| Filing 1 Private civil case docketed. Fee paid. Docketing Statement due for Appellant Ronald J. Streck by 10/19/2023. Transcript information sheet due by 11/06/2023. Appellant's brief due on or before 12/04/2023 for Ronald J. Streck. [1] [7343210] [23-3035] (MAN) [Entered: 10/23/2023 02:37 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
